Contact Us

Global Implantable Pulse Generator Opportunities 2025, Forecast To 2034

25 Mar, 2025

How Has the Implantable Pulse Generator Market Evolved Historically and What is its Current Size?

The implantable pulse generator market has seen considerable growth due to a variety of factors.
• The implantable pulse generator market has grown rapidly in recent years. It is expected to rise from $133.75 billion in 2024 to $148.38 billion in 2025, reflecting a CAGR of 10.9%.
The growth is attributed to the growing number of home healthcare facilities, the increased adoption of neuromodulation in disease management, higher diagnosis rates, more medical device usage, and increased patient awareness.

What Is The Projected Growth Of The Implantable Pulse Generator Template Market?

The implantable pulse generator market is expected to maintain its strong growth trajectory in upcoming years.
• The implantable pulse generator market is expected to grow to $222.76 billion by 2029, at a CAGR of 10.7%.
Growth is attributed to increasing healthcare expenditure, patient preference for less intrusive treatments, favorable reimbursement policies, expanded application areas, and implant use in therapies. Trends include miniaturization, longer battery life, wireless connectivity, smart implantable devices, and AI and machine learning integration.

What Are The Key Drivers Fueling Growth In The Implantable Pulse Generator Market?

The increasing prevalence of neurological disorders is expected to boost the implantable pulse generator market. Neurological disorders, affecting the brain, spinal cord, and nervous system, are rising due to aging populations, environmental factors, and better diagnostic techniques. Implantable pulse generators deliver targeted electrical impulses to manage symptoms of neurological disorders. For example, by 2030, the Parkinson Foundation projected that the number of Parkinson's disease cases in the U.S. would increase from 930,000 in 2020 to 1.2 million. The rise in neurological conditions will likely propel the demand for implantable pulse generators.

What Are The Principal Market Segments In The Global Implantable Pulse Generator Industry?

The implantable pulse generator market covered in this report is segmented –
1) By Product: Implantable Cardiac Pacemakers, Implantable Defibrillators, Cochlear Implants, Implantable Nerve Stimulators (Fes), Implantable Infusion Pumps, Implantable Active Monitoring Devices
2) By Charging Type: Rechargeable, Non Rechargeable
3) By Application: Cardiovascular Diseases, Movement Disorders, Orthopedic Diseases, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics Subsegments:
1) By Implantable Cardiac Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers
2) By Implantable Defibrillators: Implantable Cardioverter Defibrillators (ICD), Subcutaneous Implantable Defibrillators (S-ICD)
3) By Cochlear Implants: Single-Channel Cochlear Implants, Multi-Channel Cochlear Implants
4) By Implantable Nerve Stimulators (Fes): Functional Electrical Stimulation (FES) Devices For Motor Function Restoration, Spinal Cord Stimulation Devices
5) By Implantable Infusion Pumps: Insulin Pumps, Pain Management Pumps, Intrathecal Drug Delivery Pumps
6) By Implantable Active Monitoring Devices: Continuous Glucose Monitoring Systems, Cardiac Monitoring Devices, Neurological Monitoring Devices

Pre-Book The Implantable Pulse Generator Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:

How Are Emerging Trends Reshaping The Dynamics Of The Implantable Pulse Generator Market?

Leading firms in the implantable pulse generator market are concentrating their efforts on creating innovative neuromodulation devices to increase the effectiveness of treatment, improve results for patients, and broaden the scope of these devices for various neurological conditions. Neuromodulation devices, which are medical devices that alter nerve activity by transmitting electrical or pharmaceutical agents directly to specific areas of the nervous system, are being developed. For instance, in November 2022, CVRx Inc, a medical device company based in the U.S., introduced the Barostim NEO2 IPG, an implantable pulse generator designed for patients undergoing therapy. The Barostim system utilizes neuromodulation to improve heart failure symptoms by transmitting electrical impulses to the baroreceptors in the wall of the carotid artery. This stimulation triggers the body's baroreflex, leading to an autonomic response in the heart. The objective of the therapy is to reestablish balance in the autonomic nervous system and relieve heart failure symptoms.

Who Are the Key Players In The Implantable Pulse Generator Market?

Major companies operating in the implantable pulse generator market are:
• Abbott Laboratories
• Medtronic PLC
• Boston Scientific Corporation
• Integer Holdings Corporation
• Livanova plc
• Inspire Medical Systems Inc.
• Nevro Corp
• Impulse Dynamics Ltd.
• Valtronic Inc.
• NeuroPace Inc.
• SPR Therapeutics Inc.
• Stimwave LLC
• SetPoint Medical
• ReShape Lifesciences Inc.
• Synapse Biomedical Inc.
• Nuvectra Medical Inc.
• NeuroSigma Inc.
• Nalu Medical Inc.
• MainStay Medical International PLC
• Dextronix Inc.
• BioControl Medical Inc.

What Are The Regional Insights Into The Implantable Pulse Generator Market?

North America was the largest region in the implantable pulse generator market in 2023. The regions covered in the implantable pulse generator market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.